This inventor holds 8 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Amgen Inc., Cytokinetics, Inc.. Active years: 2021-2026.
Company Filing History:
8 out of 2,069 
1 out of 261 
Years Active: 2021-2026
Title: The Innovative Journey of Kyle Quasdorf
Introduction
Kyle Quasdorf is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work focuses on the synthesis of complex compounds that have potential therapeutic applications.
Latest Patents
One of his latest patents is titled "Process for preparing 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione." This patent outlines a detailed process for preparing a compound that involves several steps, including the admixing of specific amines and reactive compounds in an organic solvent. Another significant patent is related to the "Synthesis of omecamtiv mecarbil," which details the synthesis of omecamtiv mecarbil dihydrochloride hydrate and various intermediates.
Career Highlights
Kyle has worked with prominent companies in the pharmaceutical industry, including Amgen Inc. and Cytokinetics, Inc. His experience in these organizations has allowed him to develop innovative solutions and contribute to groundbreaking research in drug development.
Collaborations
Throughout his career, Kyle has collaborated with talented individuals such as Sebastien Caille and Bin Peter Quan. These partnerships have fostered a creative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
Kyle Quasdorf's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his dedication to advancing medical science. His work continues to inspire future inventors and researchers in the industry.